ESR1 and breast cancer: The increased risk of developing breast cancer has been linked to atypical hyperplasia [67] which often exhibits loss of PRB, equally, altered ER expression, sole PRA expression, and preferential PRB loss is also reported in the normal breast tissue of women with germline BRCA1/2 mutations [68].